par Berghmans, Thierry ;Meert, Anne-Pascale
Référence Revue médicale de Bruxelles, 38, 3, page (175-177)
Publication Publié, 2017-06
Article révisé par les pairs
Résumé : Immunotherapy renews in non-small cell lung cancer. Antibodies directed against PD1 and PDL1, blocking the relationship between the cancer cel ls and the immune system, al lowed in randomised trials to significantly improve cancer control with an interesting survival impact of treated patients. However, it remains to determine the most benefiting populations from this expensive and potentially toxic therapy.

Documents en relation

DI-fusion